Calidi Biotherapeutics, Inc. (CLDI): Total Assets
$8.86M
As of 2025-12-31
$7.20M
As of 2026-06-30
+50.5%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.86M | -37.5% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $14.18M | +41.6% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $10.02M | +285.8% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $2.60M | -98.9% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $231.77M | n/a | 2023-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Calidi Biotherapeutics, Inc. (CLDI) | 2025-12-31 | $8.86M | -37.5% |
| Greenland Mines Ltd (GRML) | 2025-12-31 | $9.59M | +290.4% |
| Dyadic International Inc (DYAI) | 2025-12-31 | $9.95M | +0.2% |
| Creative Medical Technology Holdings, Inc. (CELZ) | 2025-12-31 | $7.81M | +17.1% |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $7.39M | -49.6% |
| Silexion Therapeutics Corp (SLXN) | 2025-12-31 | $7.21M | +152.0% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | $11.63M | -13.5% |
| Exozymes Inc. (EXOZ) | 2025-12-31 | $5.97M | -54.2% |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | $5.78M | -32.8% |
Compare CLDI, GRML, DYAI, CELZ side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗